Location of Repository

Hypothalamic Orexin-A Neurons Are Involved in the Response of the Brain Stress System to Morphine Withdrawal

By M. Luisa Laorden, Szilamér Ferenczi, Bernadett Pintér-Kübler, Laura L. González-Martín, M. Carmen Lasheras, Krisztina J. Kovács, M. Victoria Milanés and Cristina Núñez

Abstract

Both the hypothalamus-pituitary-adrenal (HPA) axis and the extrahypothalamic brain stress system are key elements of the neural circuitry that regulates the negative states during abstinence from chronic drug exposure. Orexins have recently been hypothesized to modulate the extended amygdala and to contribute to the negative emotional state associated with dependence. This study examined the impact of chronic morphine and withdrawal on the lateral hypothalamic (LH) orexin A (OXA) gene expression and activity as well as OXA involvement in the brain stress response to morphine abstinence. Male Wistar rats received chronic morphine followed by naloxone to precipitate withdrawal. The selective OX1R antagonist SB334867 was used to examine whether orexins' activity is related to somatic symptoms of opiate withdrawal and alterations in HPA axis and extended amygdala in rats dependent on morphine. OXA mRNA was induced in the hypothalamus during morphine withdrawal, which was accompanied by activation of OXA neurons in the LH. Importantly, SB334867 attenuated the somatic symptoms of withdrawal, and reduced morphine withdrawal-induced c-Fos expression in the nucleus accumbens (NAc) shell, bed nucleus of stria terminalis, central amygdala and hypothalamic paraventricular nucleus, but did not modify the HPA axis activity. These results highlight a critical role of OXA signalling, via OX1R, in activation of brain stress system to morphine withdrawal and suggest that all orexinergic subpopulations in the lateral hypothalamic area contribute in this response

Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:3348891
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Preview

    Citations

    1. (2000). A selective orexin-1 receptor antagonist reduces food consumption in male and female rats.
    2. (2007). Activation in extended amygdala corresponds to altered hedonic processing during protracted morphine withdrawal.
    3. (2008). Addiction and the brain antireward system.
    4. (2010). Antagonism of orexin type 1 receptors in the locus coeruleus attenuates signs of naloxoneprecipitated morphine withdrawal in rats.
    5. (2006). Arousal and reward: a dichotomy in orexin function.
    6. (2004). Centrally administered orexin-A activates corticotropin-releasing factor-containing neurons in the hypothalamic paraventricular nucleus and central amygdaloid nucleus of rats: possible involvement of central orexins on stress-activated central CRF neurons.
    7. (2000). Centrally administered orexin/hypocretin activates HPA axis in rats.
    8. (2011). CRF(2) mediates the increased noradrenergic activity in the hypothalamic paraventricular nucleus and the negative state of morphine withdrawal in rats.
    9. (2000). Differential role of corticotropin-releasing factor receptor subtypes 1 and 2 in opiate withdrawal and in relapse to opiate dependence.
    10. (1998). Distribution of orexin receptor mRNA in the rat brain.
    11. (2010). Drug-induced and genetic alterations in stress-responsive systems: Implications for specific addictive diseases.
    12. (2002). Elevated extracellular CRF levels in the bed nucleus of the stria terminalis during ethanol withdrawal and reduction by subsequent ethanol intake.
    13. (2006). Excitatory action of hypocretin/orexin on neurons of the central medial amygdala.
    14. Gonza ´lez-Cuello A, Milane ´s MV (2000) Changes in catecholaminergic pathways innervating paraventricular nucleus and pituitaryadrenal axis response during morphine dependence: implication of a1- and a2-adrenoceptors.
    15. (1989). Identification of morphine- and cyclic AMPregulated phosphoprotein (MARPPs) in the locus coeruleus and other regions of rat brain: regulation by acute and chronic morphine.
    16. (2007). Inhibitory effects of an orexin-2 receptor antagonist on orexin A- and stress-induced ACTH responses in conscious rats.
    17. (2010). Interactions of orexins/hypocretins with adrenocortical functions.
    18. (2010). Intracerebroventricular injection of orexin-A stimulates monoamine metabolism but not HPA axis in neonatal chicks.
    19. (2003). Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal.
    20. (2007). Kova ´cs KJ
    21. (1999). Narcolepsy in orexin Knockout Mice: Molecular Genetics of Sleep Regulation.
    22. (2002). Neural correlates of the motivational and somatic components of naloxone-precipitated morphine withdrawal.
    23. (1998). Neurons Containing Hypocretin (Orexin) Project to Multiple Neuronal Systems.
    24. (2000). Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion.
    25. (2009). Nu ´n ˜ez C, Fo ¨ldes A, Pe ´rez-Flores D, Garcı ´a-Borro ´n
    26. (1990). Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal.
    27. (2002). Orexin actions in hypothalamic paraventricular nucleus: physiological consequences and cellular correlates.
    28. (2008). Orexin mediates the expression of precipitated morphine withdrawal and concurrent activation of the nucleus accumbens shell.
    29. (1998). Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior.
    30. (2011). Orexins in the midline thalamus are involved in the expression of conditioned place aversion to morphine withdrawal.
    31. (2003). Overlapping distributions of orexin/hypocretin- and dopamine-b-hydroxylase immunoreactive fibers in rat brain regions mediating arousal, motivation, and stress.
    32. (1991). Physiology and Pharmacology of corticotropin releasing factor.
    33. (1994). Prolonged tolerance, dependence and abstinence following subcutaneous morphine pellets implantation in the rat.
    34. (1996). Reduction of morphine abstinence in mice with a mutation in the gene encoding CREB.
    35. (2004). Role of noradrenergic projections to the bed nucleus of the stria terminalis in the regulation of the hypothalamic-pituitaryadrenal axis.
    36. (1999). The bed nucleus of the stria terminalis. A target site for noradrenergic actions in opiate withdrawal.
    37. (2009). The brain hypocretins and their receptors: mediators of allostatic arousal.
    38. (1998). The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity.
    39. (2006). The orexin system regulates alcohol-seeking in rats.
    40. (1982). The organization of noradrenergic pathways from the brainstem to the paraventricular and supraoptic nuclei in the rat.
    41. (2007). The rat brain in stereotaxic coordinates.
    42. (2004). Time-Dependent Alterations in mRNA Expression of Brain Neuropeptides Regulating Energy Balance and Hypothalamo-Pituitary-Adrenal Activity after Withdrawal from Intermittent Morphine Treatment.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.